Bayer | BAYN - Market Capitalization

Stock Price
42.59
Daily Change
0.25 0.58%
Monthly
-8.15%
Yearly
84.87%
Q1 Forecast
42.20

Bayer reported EUR41.65B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Air Liquide EUR 92.72B 8.6B Dec/2025
Akzo Nobel EUR 9.74B 626.11M Feb/2026
Alcon AG USD 29.11B 5.61B Sep/2025
Amarin USD 341M 4M Sep/2025
Arkema EUR 4.08B 680.74M Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
BASF EUR 37.83B 473.04M Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Corteva USD 49.9B 4.61B Feb/2026
Covestro EUR 11.01B 430.92M Sep/2025
Essilor EUR 113.92B 11.13B Feb/2026
Fresenius EUR 28.86B 2.16B Feb/2026
Fresenius Medical Care EUR 11.19B 770.21M Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Givaudan CHF 35.47B 1.15B Jun/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Henkel EUR 27.85B 6.57B Jun/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Linde USD 183.96B 37.84B Feb/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Nutrien USD 47.64B 17.8B Feb/2026
Philips EUR 24.21B 1.83B Feb/2026
PPG Industries USD 27.42B 4.43B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
SAP EUR 255.96B 24.02B Dec/2025
Solvay EUR 2.9B 23.69M Feb/2026
UCB EUR 32.47B 4.91B Jun/2025
Umicore EUR 4.41B 1.61M Feb/2026
Vinci EUR 75.89B 6.05B Feb/2026